The Pharma Letter3h
Wegovy label should be extended, CHMP recommends
The European Medicines Agency’s (EMA) advisory committee the CHMP has adopted a positive opinion for a label update of Danish ...
GLP-1 pills are coming, and they could revolutionize weight-loss treatment
At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...
What the Fed’s Big Rate Cut Reveals About the Economy
Investors have sent stocks and bonds higher on expectations of a soft landing. But some Republicans think the central bank ...
The Pharma Letter8d
Novo Nordisk shares up on promise of latest obesity asset
Shares in Novo Nordisk rose by about 2% on Wednesday, driven by positive data from its new obesity drug, amycretin, which ...
WebMD2d
Considering Zepbound in Vials? Here Are Some Starter Tips
The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...
Multiple Strong Catalysts And Attractive Valuation Make Novo Nordisk A Buy
Novo Nordisk has multiple, strong upcoming, positive catalysts, related to its GLP-1 weight-loss drugs, Ozempic and Wegovy.
Wegovy, Ozempic may someday be available as monthly injection
A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the ...
healthday on MSN10d
Wegovy, Ozempic May Someday Be Given as Once-Monthly Injection
A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of ...
Newsweek17d
Cheaper Weight Loss Injections Come at a Cost
However, unlike Wegovy and Ozempic ... which combines the drug and injector needle in a single applicator. But to cut down on costs and production timelines, the new version of the drug comes ...